SCHEMBL26676116

SCHEMBL26676116

COc1ccc2c(c1)c(=O)ccn2F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.48
▸ KDM4E B2RXH2 6/20 0.48
▸ HPGD P15428 6/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ MAPT P10636 5/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RAB9A P51151 4/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7285807 0.78 KDM4E (0.56) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL16536963 0.74 ALDH1A1 (0.46) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL15099945 0.73 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL16536117 0.73 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL16543633 0.73 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL16536004 0.73 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
Hydrochloric Acid SCHEMBL16536006 0.72 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL29842568 0.71 KDM4E (0.40) ALDH1A1KDM4EHPGDSMN1; SMN2NPSR1
SCHEMBL19610996 0.70 KDM4E (0.48) ALDH1A1KDM4EMAPTL3MBTL1KMT2A
SCHEMBL6222317 0.70 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN TRPV1, SCN3A, KCNN3 ALDH1A1 1762/4885KDM4E 4346/4885HPGD 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback